Showing results (81-90 of 418) with videos related to

Sort By:
Pageof 42
Biochimica Et Biophysica Acta|August 21, 2014
Tissue-specific actions of FXR in metabolism and cancerRaffaella Maria Gadaleta, Marica Cariello, Carlo Sabbà, et al.
Nutrients|August 12, 2022
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the "Bile Acid Code"Raffaella Maria Gadaleta, Marica Cariello, Lucilla Crudele, et al.
Expert Review of Gastroenterology & Hepatology|September 9, 2025
Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scoresFabio Novielli, Carlo De Matteis, Antonio Moschetta, et al.
Endocrine Development|September 6, 2017
Role of Incretin Hormones in Bowel DiseasesTamara Zietek, Nadine Waldschmitt, Eva Rath
Cell Reports|March 25, 2014
Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in miceChiara Degirolamo, Stefania Rainaldi, Fabiola Bovenga, et al.
Gut|September 9, 2011
Bacterial proteases in IBD and IBSNatalie Steck, Kerstin Mueller, Michael Schemann, et al.
Environmental Microbiology|February 28, 2009
Reduced microbial diversity and high numbers of one single Escherichia coli strain in the intestine of colitic miceSteffen Wohlgemuth, Dirk Haller, Michael Blaut, et al.
Postgraduate Medical Journal|December 22, 2012
Republished: bacterial proteases in IBD and IBSNatalie Steck, Kerstin Mueller, Michael Schemann, et al.
International Journal of Systematic and Evolutionary Microbiology|January 8, 2013
Parvibacter caecicola gen. nov., sp. nov., a bacterium of the family Coriobacteriaceae isolated from the caecum of a mouseThomas Clavel, Cédric Charrier, Mareike Wenning, et al.
Inflammatory Bowel Diseases|May 23, 2018
Microbial Signatures as a Predictive Tool in IBD-Pearls and PitfallsNadine Waldschmitt, Amira Metwaly, Sandra Fischer, et al.
Pageof 42